Segall Bryant & Hamill’s TG Therapeutics TGTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.82M | Sell |
78,270
-7,201
| -8% | -$259K | 0.04% | 382 |
|
|
2025
Q1 | $3.37M | Buy |
85,471
+5,953
| +7% | +$235K | 0.05% | 363 |
|
|
2024
Q4 | $2.39M | Buy |
79,518
+27,128
| +52% | +$817K | 0.03% | 412 |
|
|
2024
Q3 | $1.23M | Buy |
+52,390
| New | +$1.23M | 0.02% | 492 |
|
|
2021
Q2 | – | Sell |
-5,000
| Closed | -$241K | – | 823 |
|
|
2021
Q1 | $241K | Hold |
5,000
| – | – | ﹤0.01% | 763 |
|
|
2020
Q4 | $260K | Buy |
+5,000
| New | +$260K | ﹤0.01% | 675 |
|
|
2018
Q1 | – | Sell |
-61,092
| Closed | -$501K | – | 622 |
|
|
2017
Q4 | $501K | Buy |
61,092
+7,500
| +14% | +$61.5K | 0.01% | 420 |
|
|
2017
Q3 | $635K | Hold |
53,592
| – | – | 0.01% | 398 |
|
|
2017
Q2 | $539K | Buy |
53,592
+8,092
| +18% | +$81.4K | 0.01% | 419 |
|
|
2017
Q1 | $530K | Buy |
45,500
+30,000
| +194% | +$349K | 0.01% | 404 |
|
|
2016
Q4 | $72K | Buy |
+15,500
| New | +$72K | ﹤0.01% | 533 |
|